Authors' Response to a Letter to the Editor.

about

Authors' Response to a Letter to the Editor.

Item

http://www.wikidata.org/entity/Q46291590

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Authors' Response to a Letter to the Editor.

@en

Authors' Response to a Letter to the Editor.

@nl

type

Item

label

Authors' Response to a Letter to the Editor.

@en

Authors' Response to a Letter to the Editor.

@nl

prefLabel

Authors' Response to a Letter to the Editor.

@en

Authors' Response to a Letter to the Editor.

@nl

P1476

Authors' Response to a Letter to the Editor

@en

P2093

F G Holz

http://www.w3.org/2001/XMLSchema#string

P2860

Preclinical aspects of anti-VEGF agents for the treatment of wet AMD: ranibizumab and bevacizumab

Comment on 'Preclinical aspects of anti-VEGF agents for the treatment of wet AMD: ranibizumab and bevacizumab'.

Research Methods & Reporting. Good publication practice for communicating company sponsored medical research: the GPP2 guidelines.

P304

167-168

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/EYE.2011.261

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

C H Meyer

P577

2011-11-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P932

3259591

http://www.w3.org/2001/XMLSchema#string